Status:
UNKNOWN
Continuous Glucose Monitoring and Cerebral Oxygenation in Preterm Infants
Lead Sponsor:
University Hospital Padova
Collaborating Sponsors:
University of Padova
Conditions:
Infant Development
Hypoglycemia Neonatal
Eligibility:
All Genders
2-2 years
Phase:
NA
Brief Summary
Neonatal hypoglicaemia is associated with impaired neurodevelopment outcomes in preterm infants. Thus, hypoglicemic events should be diagnosed and treated promptly. Unfortunately, hypo- and hyperglica...
Detailed Description
Background - Hypoglycaemia is a very common event during the first week of life, it affects up to 15% of term newborns and it is more frequent in preterm and IUGR (Intrauterine Growth Restriction with...
Eligibility Criteria
Inclusion
- \<= 32 weeks gestation
- birthweight \<1500 g
Exclusion
- birthweight \<500g
- congenital pathologies
- lack of parental consent
- perinatal maternal infections
- albinism
Key Trial Info
Start Date :
April 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04347590
Start Date
April 24 2020
End Date
April 30 2025
Last Update
November 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neonatal Intensive Care Unit - University Hospital of Padua
Padua, Italy, 35128